SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-23-000049
Filing Date
2023-05-09
Accepted
2023-05-09 16:54:09
Documents
95
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20230331x10q.htm   iXBRL 10-Q 2084542
2 EX-10.1 amph-20230331xex10d1.htm EX-10.1 78207
3 EX-31.1 amph-20230331xex31d1.htm EX-31.1 19162
4 EX-31.2 amph-20230331xex31d2.htm EX-31.2 18817
5 EX-32.1 amph-20230331xex32d1.htm EX-32.1 9831
6 EX-32.2 amph-20230331xex32d2.htm EX-32.2 9832
  Complete submission text file 0001297184-23-000049.txt   9674480

Data Files

Seq Description Document Type Size
7 EX-101.SCH amph-20230331.xsd EX-101.SCH 64082
8 EX-101.CAL amph-20230331_cal.xml EX-101.CAL 62586
9 EX-101.DEF amph-20230331_def.xml EX-101.DEF 273016
10 EX-101.LAB amph-20230331_lab.xml EX-101.LAB 486975
11 EX-101.PRE amph-20230331_pre.xml EX-101.PRE 437066
89 EXTRACTED XBRL INSTANCE DOCUMENT amph-20230331x10q_htm.xml XML 1900785
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 23903038
SIC: 2834 Pharmaceutical Preparations